HealthcareServices

Chronic Pancreatitis (CP) Market Size and Growth Forecast for Businesses 2025–2029

November 27, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Chronic Pancreatitis (CP) Market Size During 2025–2029?

The chronic pancreatitis (cp) market size has experienced significant expansion over recent years. Forecasts show it will ascend from $4.91 billion in 2024 to $5.23 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.4%. The historical increase can be attributed to several elements, including the rising prevalence of alcohol consumption, an increasing incidence of smoking, genetic predisposition and family history, enhanced awareness of pancreatic diseases, a rise in diabetes cases connected to pancreatitis, increased healthcare spending, and better access to healthcare services.

The market size for chronic pancreatitis (cp) is projected to experience substantial expansion in the coming years. It is anticipated to reach $6.66 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period can be attributed to an expanding elderly population, a heightened demand for enzyme replacement therapies, improved understanding leading to earlier diagnosis, improvements in healthcare infrastructure within developing regions, the introduction of innovative pain management solutions, and a rise in research and clinical studies focused on pancreatitis treatment. Significant trends expected to shape the market over this period encompass the application of artificial intelligence in diagnostic imaging, advancements in minimally invasive surgical methods, the use of wearables for ongoing health surveillance, next-generation sequencing for genetic analysis, the incorporation of machine learning to track disease progression, and the creation of intelligent diagnostic instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21146&type=smp

Which Drivers Are Shaping The Chronic Pancreatitis (CP) Industry’s Market Share?

The growth of the chronic pancreatitis market is anticipated to be driven by the rising consumption of alcohol in the future. Alcohol consumption involves ingesting ethanol-containing drinks, frequently for social, recreational, or cultural reasons, though excessive intake can result in dependency or health hazards. The escalation in alcohol consumption stems from factors like greater social acceptance, urbanization, evolving lifestyles, and methods of stress management, particularly prevalent in younger demographics. Chronic pancreatitis is caused by alcohol consumption, which initiates inflammation and harm to pancreatic cells, subsequently resulting in fibrosis, obstructions in the ducts, and sustained dysfunction attributed to harmful metabolic byproducts. As an illustration, a publication from Kirin Holdings Company Limited, a Japan-based beer and beverage holding company, indicated in December 2023 that worldwide beer consumption in 2022 increased by approximately 5.4 million kiloliters (which equals about 8.5 billion 633ml bottles) from 2021, achieving a total of around 192.1 million kiloliters. This 2.9% rise, translating to roughly 303.5 billion 633ml bottles, was ascribed to the reduced influence of COVID-19. Consequently, the rising intake of alcohol is fueling the expansion of the chronic pancreatitis market.

What Are The Emerging Segments Gaining Attention In The Chronic Pancreatitis (CP) Market?

The chronic pancreatitis (cp)market covered in this report is segmented –

1) By Treatment: Analgesic; Artificial Digestive Enzyme; Protein Supplements; Steroids; Antibiotics; Other Treatments

2) By Diagnosis: Computed Tomography (CT) Scan; Magnetic Resonance Cholangiopancreatography; Ultrasound Sonography; Other Diagnosis

3) By Route Of Administration: Oral; Parenteral

4) By End User: Hospitals; Homecare; Other End Users

Subsegments:

1) By Analgesic: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids

2) By Artificial Digestive Enzyme: Pancrelipase; Pancreatin

3) By Protein Supplements: Branched-Chain Amino Acids (BCAA); Whey Protein

4) By Steroids: Prednisone; Dexamethasone

5) By Antibiotics: Ciprofloxacin; Metronidazole

6) By Other Treatments: Endoscopic Treatment; Surgery

Which Ongoing Trends Are Expected To Shape The Chronic Pancreatitis (CP) Market Outlook?

Leading companies operating in the chronic pancreatitis market are concentrating on developing technological advancements, notably enzyme replacement therapy, to address exocrine pancreatic insufficiency (EPI) associated with chronic pancreatitis. This therapy involves the oral intake of pancreatic enzymes to assist digestion in patients experiencing insufficient pancreatic function. For instance, in July 2023, First Wave BioPharma Inc, a US-based clinical-stage biopharmaceutical company, announced the results from the Phase 2 SPAN clinical trial, which investigated an enhanced enteric microgranule delivery formulation of adrulipase for treating exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis. Adrulipase is a recombinant lipase enzyme derived from the Yarrowia lipolytica yeast, administered as an oral, non-systemic biologic capsule, designed to break up fat molecules in the digestive tract of EPI patients to enable their absorption as nutrients.

Which Industry Leaders Are Driving Innovation Across The Chronic Pancreatitis (CP) Market?

Major companies operating in the chronic pancreatitis (CP) market are Pfizer, Johnson & Johnson, Merck & Co Inc, AbbVie Inc, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Baxter, CSL Behring, Octapharma AG, Dr. Reddy’s Laboratories, Nestle Health Science, Cerata Pharmaceuticals, Unichem Laboratories Ltd, LGM Pharma, Aptalis Pharmaceutical Technologies, Digestive Care Inc, Akron Biotech

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

What Are The Key Regional Factors Influencing The Chronic Pancreatitis (CP) Market Growth?

North America was the largest region in the chronic pancreatitis (CP) market in 2024. The regions covered in the chronic pancreatitis (cp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Pancreatitis (CP) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21146&type=smp

Browse Through More Reports Similar to the Global Chronic Pancreatitis (CP) Market 2025, By The Business Research Company

Chronic Lower Back Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Chronic Obstructive Pulmonary Disease Copd Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Chronic Lymphocytic Leukemia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-lymphocytic-leukemia-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795